Timing of Rivaroxaban Discontinuation Before Hernia Repair
For patients with normal renal function, rivaroxaban (Xarelto) should be stopped at least 24 hours before hernia repair surgery, as this is considered a low-to-moderate bleeding risk procedure. 1
Evidence-Based Recommendations for Rivaroxaban Discontinuation
The timing of rivaroxaban discontinuation before surgery depends on two key factors:
- The bleeding risk associated with the procedure
- The patient's renal function
For Hernia Repair (Low-to-Moderate Bleeding Risk Procedure):
- Normal renal function (CrCl ≥50 mL/min): Stop rivaroxaban 1 day before surgery (skip 1 dose) 1
- Moderate renal impairment (CrCl 30-50 mL/min): Stop rivaroxaban 2 days before surgery (skip 1 dose) 1
- Severe renal impairment (CrCl 15-29.9 mL/min): Stop rivaroxaban 3 days before surgery (skip 2 doses) 1
Dosing Schedule Based on Administration Time:
For once-daily rivaroxaban regimen with normal renal function:
- Morning intake: Last dose should be on the morning of the day before the procedure 1
- Evening intake: Last dose should be two days before the procedure 1
Resumption of Anticoagulation After Surgery
Rivaroxaban can be resumed after surgery based on the following guidelines:
- Resume at least 6 hours after the end of the procedure if there is no ongoing bleeding 1
- For once-daily regimen with morning intake: Resume the next morning after surgery 1
- For once-daily regimen with evening intake: Resume the evening of the surgery day 1
Important Considerations
- No bridging therapy needed: Preoperative bridging with heparin is not recommended when interrupting rivaroxaban 1
- No routine laboratory monitoring required: There is no need to measure rivaroxaban concentration before the procedure when following the recommended interruption periods 1
- Bleeding risk: An INR >3 increases the risk of postoperative hematoma in hernia repair 2
- Rapid onset of action: Rivaroxaban has a peak effect occurring 1-3 hours after intake, requiring cautious administration after surgery 1
Special Situations
- If the hernia repair involves neuraxial anesthesia (spinal/epidural), consider a longer interruption time of up to 5 days for rivaroxaban in patients with normal renal function 1
- For emergency hernia repair, the FDA label states that rivaroxaban should be stopped at least 24 hours before the procedure to reduce bleeding risk 3
Postoperative Considerations
- If venous thromboprophylaxis is indicated after surgery but rivaroxaban resumption must be delayed due to bleeding risk, consider heparin or fondaparinux starting at least 6 hours after the procedure 1
- Monitor for signs of bleeding after resuming rivaroxaban, particularly at the surgical site
Following these evidence-based guidelines for perioperative management of rivaroxaban will help minimize both bleeding and thrombotic risks during hernia repair surgery.